Demetra and Masmec Biomed Collaborate on AI-Enhanced Surgery
Demetra Holding has entered into a strategic collaboration with Masmec Biomed. The partnership aims to advance surgical solutions powered by AI, navigation, and robotics.

MILAN, July 22, 2026 – Demetra Holding, a company specializing in orthopedic and spine surgery technologies, has announced a strategic collaboration with Masmec Biomed. This partnership seeks to combine Demetra's clinical expertise with Masmec's deep knowledge in biomedical engineering, artificial intelligence, and surgical navigation systems to develop a new generation of surgically enhanced solutions.
The collaboration will focus on leveraging artificial intelligence, robotics, navigation systems, and data. Demetra brings its established experience in the orthopedic, neuro, and spine sectors, along with an international presence. Masmec Biomed contributes specialized competencies in biomedical engineering and advanced technologies derived from their work in high-complexity industries.
"Our ambition is not simply to participate in this change, but to help build it, reflecting a transformation that is set to redefine the MedTech sector," said Michele Perrino, CEO of Demetra Holding. "We aim to build a new industrial model connecting clinical expertise, artificial intelligence, navigation, robotics, and data to make surgery more precise, predictive, and personalized."
Market analyses indicate that surgical navigation and artificial intelligence represent rapidly growing segments within the medical technology sector. Through this collaboration, Demetra aims to establish itself as a European platform for clinical and technological innovation, accelerating the adoption of advanced solutions. Masmec Biomed's CEO Daniela Vinci stated that the shared vision focuses on personalized care enabled by technology.
Both companies underscore the belief that future medical advancements will stem from the integration of clinical knowledge with advanced technologies. This collaboration signifies Demetra's evolution from a leader in the spine sector to a promoter of a new European MedTech paradigm where surgery, data, and innovation converge.